Effect of Pre-injection of Rocuronium on Neuromuscular Blockade Onset Time and Hemodynamics During General Anesthesia Induction
General Hospital of Ningxia Medical University
108 participants
Jul 1, 2026
INTERVENTIONAL
Conditions
Summary
This is a single-center, prospective, randomized, controlled trial comparing pre-injection versus standard bolus administration of rocuronium bromide for general anesthesia induction. A total of 108 adult patients (18-65 years, ASA I-III) scheduled for elective surgery requiring endotracheal intubation will be enrolled and randomized 1:1 to either the pre-injection group or control group. The pre-injection group will receive rocuronium 0.06 mg/kg as a priming dose followed by 0.54 mg/kg 3 minutes later. The control group will receive rocuronium 0.6 mg/kg as a single bolus. All patients will receive standardized anesthesia induction with midazolam and propofol. The primary outcome is neuromuscular blockade onset time (seconds). Secondary outcomes include hemodynamic parameters (SBP, DBP, MAP, HR, CO, SV, SVR), injection pain incidence, and adverse events. This study aims to investigate whether pre-injection of rocuronium can shorten neuromuscular blockade onset time while maintaining hemodynamic stability compared to standard bolus administration.
Eligibility
Inclusion Criteria5
- Aged from 18 to 65 years old
- American Society of Anesthesiologists (ASA) physical status classification Ⅰ, Ⅱ or Ⅲ
- Elective surgery requiring general anesthesia with tracheal intubation
- Able to understand the study and voluntarily sign written informed consent
- Male or female, no gender restriction
Exclusion Criteria8
- Severe hepatic dysfunction (ALT/AST > 3 times the upper limit of normal) or renal dysfunction (creatinine > 2 times the upper limit of normal)
- Central nervous system diseases or severe neuromuscular disorders
- Severe arrhythmia or cardiac dysfunction (NYHA class Ⅲ-Ⅳ, or ejection fraction EF < 30%)
- Known hypersensitivity or allergy to rocuronium, midazolam, propofol or other study-related drugs
- Refusal to participate in this clinical trial
- Pregnant or breastfeeding women
- History of predicted difficult airway requiring awake tracheal intubation
- Contraindications to rapid sequence induction
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Low-dose rocuronium bromide is injected intravenously in advance before anesthesia induction
Rocuronium bromide is administered by standard routine intravenous injection during anesthesia induction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07716891